In line with what has been shown in AD animal models, strengthening the gut-brain barrier through probiotic supplementation in a diabetes mouse model down-regulated GSK-3β levels compared to the diseased group without probiotic supplementation (Yan et al., 2019). The gene discussed is GSK3B; the disease is diabetes mellitus.